Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Lacto-N-difucohexaose-1 | LNF-1 human milk saccharide, contains blood group O (H) type I determinant. Product ID: 3-00424. Molecular formula: C38H65NO29. Mole weight: 999.91. Reference: Anal. Biochem., 133, 1, 1983. |  |
| Lacto-N-difucohexaose-2 | Lacto-N-difucohexaose-2. Product ID: 3-02365. Molecular formula: C38H65NO29. Mole weight: 999.91. | |
| Lacto-N-difucohexaose I | Lacto-N-difucohexaose I is an indispensable compound in the biomedical field, exhibiting remarkable immunomodulatory attributes. Its application predominantly encompasses the research of multifarious ailments, encompassing particular cancer types and autoimmune afflictions. As a propitious research, this product adeptly modulates the immune response, potentially augmenting patient outcomes with unprecedented efficacy. Synonyms: LNDFH I; Lewisb antigen; 6-Deoxy-α-L-galactopyranosyl-(1->4)-[6-deoxy-α-L-galactopyranosyl-(1->2)-β-D-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1->3)-β-D-galactopyranosyl-(1->4)-D-glucose; α-L-Fuc-(1-2)-β-D-Gal-(1-3)[α-L-Fuc-(1-4)]-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-D-Glc. Grades: ≥95%. CAS No. 16789-38-1. Molecular formula: C38H65NO29. Mole weight: 999.91. |  |
| Lacto-N-difucohexaose I-APD-HSA | | |
| Lacto-N-difucohexaose I-APD-KLH | | |
| Lacto-N-difucohexaose I-BSA | | |
| Lacto-N-difucohexaose I-BSA (LNDFH I-BSA) (3 atom spacer) | It is a lewisb antigen linked to lactose spacer, a structure recognized by Helicobacter pylori that binds to human gastric epithelium. | |
| Lacto-N-difucohexaose II | Lacto-N-difucohexaose II, a carbohydrate compound prevalent in the biomedical industry for research purposes, has been found to impede pathogen adhesion to human intestinal cells. This realization has spurred speculation on the potential of Lacto-N-difucohexaose II as a viable candidate in the development of drug interventions for infectious maladies afflicting the gut. Equally exciting, Lacto-N-difucohexaose II may also offer promise as a cancer treatment. Synonyms: LNDFH II; Lewis A hexaose; D-Glucose, O-6-deoxy-alpha-L-galactopyranosyl-(1-3)-O-(O-6-deoxy-alpha-L-galactopyranosyl-(1-4)-O-(beta-D-galactopyranosyl-(1-3))-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-3)-beta-D-galactopyranosyl-(1-4))-; β-D-Gal-(1-3)-[α-L-Fuc-(1-4)]-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-[α-L-Fuc-(1-3)]-D-Glc. Grades: ≥95%. CAS No. 62258-12-2. Molecular formula: C38H65NO29. Mole weight: 999.91. | |
| Lacto-N-difucohexaose IV | Lacto-N-difucohexaose IV, recognized as a pivotal compound constituent, presents itself as a prospective remedial aide for an array of ailments like bacterial and viral infections. By focusing on distinct receptors and impeding the proliferation of malevolent microorganisms, this indispensable compound extensively contributes to the research of pathogenic infections. Its exceptional efficacy renders it an invaluable compound for biomedical drug advancement. Synonyms: LNDFH IV. Molecular formula: C38H65NO29. Mole weight: 999.91. | |
Our database is helping our users find suppliers everyday.
